The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 501–600 of 1,001
Early evolution: prokaryotes, the new kids on the block
Poole, A., Jeffares, D., & Penny, D. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199910)21:10<880::aid-bies11>3.0.co;2-p · Cited by 178
Integrating Physiological Regulation with Stem Cell and Tissue Homeostasis
Nakada, D., Levi, B. P., & Morrison, S. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.011 · Cited by 86
The trithorax-group and Polycomb-group chromatin modifiers: implications for disease
van Lohuizen, M. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80053-7 · Cited by 78
Schlüter, H., Paquet‐Fifield, S., Gangatirkar, P., Li, J., & Kaur, P. (2011) · Stem Cells · doi:10.1002/stem.675 · Cited by 81
Ras-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76
“The molecular links driving the accumulation of p16INK4A and p19ARF, both products of the INK4A locus, at the onset of senescence, have been at least part elucidated with the discovery that the polycomb protein Bmi1 represses transcription of the INK4A locus in normal culture conditions but is released upon oncogenic…”
BackgroundHaruta, M., Tomita, Y., Yuno, A., Matsumura, K., Ikeda, T., Takamatsu, K., Haga, E., Koba, C., Nishimura, Y., & Senju, S. (2012) · Gene Therapy · doi:10.1038/gt.2012.59 · Cited by 80
Choy, B., Lalonde, A., Que, J., Wu, T., & Zhou, Z. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.07.013 · Cited by 77
“Bmi1 is a member of the polycomb-group proteins and functions as a stem cell marker to regulate the proliferation of progenitor cells [22].”
BackgroundAgeing as developmental decay: insights from p16INK4a.
Martin, N., Beach, D., & Gil, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.008 · Cited by 76
Lu, L., Xu, H., Luo, F., Liu, X., Lü, X., Yang, Q., Xue, J., Chen, C., Shi, L., & Liu, Q. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.05.012 · Cited by 76
Epigenetics in T‐cell acute lymphoblastic leukemia
Peirs, S., der Meulen, J. V., de Walle, I. V., Taghon, T., Speleman, F., Poppe, B. G., & Vlierberghe, P. V. (2014) · Immunological Reviews · doi:10.1111/imr.12237 · Cited by 80
“Although the full spectrum of PRC2 target genes in the context of normal and malignant T-cell transformation remains to be established, it has been shown that this chromatin-remodeling complex can mediate silencing of the Ink4a-Arf locus in hematopoietic precursors (77, 78).”
BackgroundShin, M. S., Fredrickson, T. N., Hartley, J. W., Suzuki, T., Agaki, K., & Morse, H. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3885 · Cited by 76
Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis
Lessard, J. A., & Sauvageau, G. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00081-x · Cited by 87
“Conversely, overexpression of Bmi-1 in MEFs was found to down-regulate the expression of p16 and p19, delay replicative senescence, and facilitate immortalization [154].”
BackgroundInfluentialTumour suppressor retinoblastoma protein Rb: A transcriptional regulator
Zhu, L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.009 · Cited by 92
“It was later determined that Bmi1 is a potent repressor of the Ink4a/ Arf locus [107], which encodes both p16Ink4a and p14Arf.”
BackgroundSingle-cell transcriptional analysis of normal, aberrant, and malignant hematopoiesis in zebrafish
Moore, F. E., Garcia, E. G., Lobbardi, R., Jain, E., Tang, Q., Moore, J. C., Cortes, M., Molodtsov, A., Kasheta, M., Luo, C. C., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20152013 · Cited by 77
“BMI1 confers self-renewal properties to a variety of solid and hematological tumors, including multiple subtypes of T-ALL (Jacobs et al., 1999; Lessard and Sauvageau, 2003; Sayito ğ lu et al., 2012; Saudy et al., 2014).”
BackgroundKeenen, B., & de la Serna, I. L. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21654 · Cited by 82
“…Baf specific subunits, Baf250a or b into the SWI/SNF complex is also modulated during differentiation, such that Baf250a is incorporated to a greater extent prior to differentiation and Baf250b is incorporated to a greater extent after differentiation with retinoic acid (Kaeser et al., 2008).”
BackgroundSenescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG
Balakrishnan, I., Danis, E., Pierce, A., Madhavan, K., Wang, D., Dahl, N., Sanford, B., Birks, D. K., Davidson, N., Metselaar, D. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108286 · Cited by 69
“Given that the oncogenic role of BMI1 is to repress the transcription of tumor suppressors, including p21 and p16, with the latter as the best-known target for cell growth arrest and senescence (Jacobs et al., 1999), we hypothesized that this increased survival could result from increase in tumor suppressors.”
BackgroundTonini, T., D’Andrilli, G., Fucito, A., Gaspa, L., & Bagella, L. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21241 · Cited by 83
“Its upregulation induces downregulation of p16INK4a and p19ARF leading to development of B- and T-cell lymphoma (Alkema et al., 1997b; Jacobs et al., 1999a,b).”
BackgroundAoto, T., Saitoh, N., Sakamoto, Y., Watanabe, S., & Nakao, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709322200 · Cited by 71
Epigenetic Factors in Cancer Development: Polycomb Group Proteins
Piunti, A., & Pasini, D. (2011) · Future Oncology · doi:10.2217/fon.10.157 · Cited by 73
“BMI-1-deficient mouse embryonic fibroblasts undergo a dramatic block of proliferation and a strong activation of p15, p19 and p16 [160].”
BackgroundMechanisms regulating epidermal stem cells
Beck, B., & Blanpain, C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.67 · Cited by 80
“…et al , 2009, 2011; Mejetta et al , 2011), they all lead to the repression of Ink4a locus encoding p16, preventing cellular senescence as it was initially discovered for Bmi1 deficiency in fibroblasts (Jacobs et al , 1999) as well as in haematopoietic and leukaemic SCs (Lessard et al , 1999).”
Mechanisms of Yin Yang 1 in Oncogenesis: The Importance of Indirect Effects
Atchison, M. L., Basu, A., Zápražná, K., & Papasani, M. R. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i3-4.20 · Cited by 77
Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14ARF-MDM2-p53 axis
Maerken, T. V., Vandesompele, J., Rihani, A., Paepe, A. D., & Speleman, F. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.138 · Cited by 82
Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
Wu, Z., Min, L., Chen, D., Hao, D., Duan, Y., Qiu, G., & Wang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014648 · Cited by 74
“BMI-1 is essential for blood-cell development and the self-renewal capacity of several types of normal and cancer stem cells [5], and it is also important for cell cycle regulation, since both p16/INK4a and p14/ARF are downstream targets of BMI-1 [6,7].”
Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells
Schuringa, J. J., & Vellenga, E. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328338c439 · Cited by 77
Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia
Bardeesy, N., Morgan, J., Sinha, M., Signoretti, S., Srivastava, S., Loda, M., Merlino, G., & DePinho, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.635-643.2002 · Cited by 74
“This lack of p19 upregulation despite loss of p53 may indicate that these tumors incurred disruption of the Ink4a/Arf locus that eluded detection or, conversely, that the locus may be subject to a trans regulatory repression mechanism (19).”
BackgroundSelf-citationPolycomb-group genes as regulators of mammalian lymphopoiesis
Raaphorst, F. M., Otte, A. P., & Meijer, C. J. L. M. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02082-8 · Cited by 75
EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development
Kunju, L. P., Cookingham, C., Toy, K. A., Chen, W., Sabel, M. S., & Kleer, C. G. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.8 · Cited by 73
“The Polycomb group (PcG) proteins form chromatin-modifying complexes essential for embryonic development and stem cell renewal and are deregulated in cancer”
ARF tumor suppression in the nucleolus
Maggi, L. B., Winkeler, C. L., Miceli, A. P., Apicelli, A. J., Brady, S. N., Kuchenreuther, M., & Weber, J. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.016 · Cited by 78
An anticlastogenic function for the Polycomb Group gene Bmi1
Chagraoui, J., Hébert, J., Girard, S., & Sauvageau, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014263108 · Cited by 69
“Flatt PM, Tang LJ, Scatena CD, Szak ST, Pietenpol JA (2000) p53 regulation of G(2) checkpoint is retinoblastoma protein dependent.”
BackgroundBlomen, V. A., & Boonstra, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0505-5 · Cited by 84
The Polycomb Group Protein Bmi-1 Is Essential for the Growth of Multiple Myeloma Cells
Jagani, Z., Wiederschain, D., Loo, A. T., He, D., Mosher, R. E., Fordjour, P., Monahan, J. E., Morrissey, M., Yao, Y.-M., Lengauer, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4229 · Cited by 81
“Bmi-1 inhibits apoptosis in MM cells In several cellular contexts, Bmi-1 has been shown to promote cell cycle progression, and counteract senescence and apoptosis by silencing the expression of p16 and p19 tumor suppressors (5, 6).”
BackgroundInfluentialBmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis
Xu, C., Lee, S., Ho, C., Bommi, P. V., Huang, S., Cheung, S., Dimri, G. P., & Chen, X. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0333 · Cited by 80
“We chose activated Ras as the second signal, based on studies that have shown that Bmi1 is capable of cooperating with activated Ras to transform cells in vitro (24, 25).”
MethodHuman epithelial cell immortalization as a step in carcinogenesis
Stampfer, M. R., & Yaswen, P. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00707-3 · Cited by 84
Hematopoietic stem cell ageing is uncoupled from p16INK4A-mediated senescence
Attema, J. L., Pronk, C. J. H., Norddahl, G. L., Nygren, J. M., & Bryder, D. (2009) · Oncogene · doi:10.1038/onc.2009.94 · Cited by 72
Kaneda, A., Fujita, T., Anai, M., Yamamoto, S., Nagae, G., Morikawa, M., Tsuji, S., Oshima, M., Miyazono, K., & Aburatani, H. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002359 · Cited by 72
Qu, K., Xu, X., Liu, C., Wu, Q., Wei, J., Meng, F., Zhou, L., Wang, Z., Lei, L., & Liu, P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.12.008 · Cited by 79
Mutually Exclusive Inactivation of DMP1 and ARF/p53 in Lung Cancer
Mallakin, A., Sugiyama, T., Taneja, P., Matise, L. A., Frazier, D. P., Choudhary, M., Hawkins, G. A., D'Agostino, R. B., Willingham, M. C., & Inoue, K. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.034 · Cited by 80
“…is negatively regulated by overexpression of nuclear proteins such as Bmi1, Twist, Tbx-2/3, and Pokemon, and overexpression of these proteins have been reported in human cancers (Brummelkamp et al., 2001; Maeda et al., 2005; Maestro et al., 1999; Jacobs et al., 1999, 2000; Yang et al., 2004).”
BackgroundThe Multiple Facets of PRC2 Alterations in Cancers
Wassef, M. A., & Margueron, R. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.10.012 · Cited by 74
Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A
Tonini, T., Bagella, L., D’Andrilli, G., Claudio, P. P., & Giordano, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207608 · Cited by 82
“…levels of almost any vertebrate PcG protein leads to cellular transformation (Haupt et al., 1991; van Lohuizen et al., 1991; Cohen et al., 1996; Jacobs et al., 1999a), but little is known about their mechanism in malignant transformation and how the PcG complexes are associated with their…”
BackgroundEfficient Immortalization of Primary Nasopharyngeal Epithelial Cells for EBV Infection Study
Yip, Y. L., Pang, P. S., Deng, W., Tsang, C. M., Zeng, M., Hau, P. M., Man, C., Jin, Y., Yuen, A. P. W., & Tsao, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078395 · Cited by 74
“expression of Bmi-1 alone could immortalize fibroblasts [22], human mammary epithelial cells [9] and human nasopharyngeal epithelial cells [4].”
Lu, X., Sun, S., Qi, J., Li, W., Liu, L.-M., Zhang, Y., Chen, Y., Zhang, S., Wang, L., Miao, D., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9686-8 · Cited by 71
Yang, D., Cui, B., Sun, L., Zheng, H., Huang, Q., Tong, J., & Zhang, Q.-F. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9229-x · Cited by 73
“The PRC1 subunit BMI-1 and the hSAGA subunit USP22 are required for appropriate transit through the cell cycle by regulating the same genes such as CDK2NA [13, 17].”
BackgroundRescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf
Su, X., Cho, M. S., Gi, Y. J., Ayanga, B. A., Sherr, C. J., & Flores, E. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.151 · Cited by 78
“…Ink4a–Arf locus by p63 is reminiscent of the effects of Bmi-1, which has an essential role in the maintenance of stem cell function in HSCs and NSCs (Jacobs et al, 1999; Molofsky et al, 2003, 2005; Park et al, 2003; Bruggeman et al, 2005; Bracken et al, 2007) but has no such function during skin…”
BackgroundInfluentialCakouros, D., & Gronthos, S. (2018) · Aging and Disease · doi:10.14336/ad.2017.1213 · Cited by 72
“BMI1 are not only integral to the regulation of MSC selfrenewal and differentiation but also regulate expression of the p16Ink4A locus [127-132].”
BackgroundRaaphorst, F. M., Otte, A. P., van Kemenade, F. J., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., & Meijer, C. J. L. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5925 · Cited by 69
The role of SOX family transcription factors in gastric cancer
Abadi, A. J., Zarrabi, A., Hashemi, F., Zabolian, A., Najafi, M., Entezari, M., Hushmandi, K., Aref, A. R., Khan, H. Z., Makvandi, P., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.202 · Cited by 73
Cancer Stem Cell Epigenetics And Chemoresistance
Crea, F., Danesi, R., & Farrar, W. L. (2009) · Epigenomics · doi:10.2217/epi.09.4 · Cited by 74
Bárdos, J. I., Saurin, A. J., Tissot, C., Duprez, E., & Freemont, P. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001835200 · Cited by 78
Wang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
Lymphoma stem cells: enough evidence to support their existence?
Martinez-Climent, J. A., Fontán, L., Gascoyne, R. D., Siebert, R., & Prósper, F. (2010) · Haematologica · doi:10.3324/haematol.2009.013318 · Cited by 81
DDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16 INK4a Activation
Kotake, Y., Zeng, Y., & Xiong, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2739 · Cited by 69
Frat is dispensable for canonical Wnt signaling in mammals
van Amerongen, R., Nawijn, M., Franca-Koh, J., Zevenhoven, J., van der Gulden, H., Jonkers, J., & Berns, A. (2005) · Genes & Development · doi:10.1101/gad.326705 · Cited by 67
“Primary MEFs were isolated and cultured according to Jacobs et al. (1999) and propagated according to a 3T3 protocol.”
MethodMarkers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
Geroconversion of aged muscle stem cells under regenerative pressure
Sousa-Victor, P., Perdiguero, E., & Muñoz-Cánoves, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.965072 · Cited by 68
Stepanova, L., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-06-2242 · Cited by 68
Genetics and epigenetics of cutaneous malignant melanoma: A concert out of tune
van den Hurk, K., Niessen, H. E. C., Veeck, J., van den Oord, J. J., Steensel, M. A. M. V., Hausen, A. Z., van Engeland, M., & Winnepenninckx, V. J. L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.011 · Cited by 79
Yadırgı, G., Leinster, V. H. L., Acquati, S., Bhagat, H., Shakhova, O., & Marino, S. (2011) · Stem Cells · doi:10.1002/stem.614 · Cited by 75
Self-citationTalati, P. G., Gu, L., Ellsworth, E., Girondo, M. A., Trerotola, M., Hoang, D. T., Leiby, B. E., Dagvadorj, A., McCue, P. A., Lallas, C. D., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.04.026 · Cited by 68
The INK4-ARF (CDKN2A/B) Locus in Hematopoiesis and BCR-ABL-induced Leukemias
Williams, R. T., & Sherr, C. J. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.039 · Cited by 81
Barradas, M., Gonos, E. S., Zebedee, Z., Kolettas, E., Petropoulou, C., Delgado, M. D., León, J., Hara, E., & Serrano, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5434 · Cited by 76
Czvitkovich, S., Sauer, S., Peters, A. H. F. M., Deiner, E., Wolf, A., Laible, G., Opravil, S., Beug, H., & Jenuwein, T. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00464-6 · Cited by 76
Role for the MOV10 RNA helicase in Polycomb-mediated repression of the INK4a tumor suppressor
Messaoudi, S. E., Nicholls, J., Maertens, G. N., Brookes, S., Bernstein, E., & Peters, G. G. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1824 · Cited by 74
Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAs
Wang, X., Wang, C., Zhang, X., Hua, R., Gan, L., Huang, M., Zhao, L., Ni, S., & Guo, W. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0323-9 · Cited by 69
“Bmi-1 is a transcriptional inhibitor and the earliest research found that Bmi-1 downregulated the expression of p16 and p19 by inhibiting INK4a/ARF and thus regulates cell proliferation and senescence [29].”
BackgroundBMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3
Liu, X., Wei, W., Li, X., Shen, P., Ju, D., Wang, Z., Zhang, R., Yang, F., Chen, C., Cao, K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.044 · Cited by 71
Zardo, G., Cimino, G. G., & Nervi, C. (2008) · Leukemia · doi:10.1038/leu.2008.141 · Cited by 74
The ENL moiety of the childhood leukemia-associated MLL–ENL oncoprotein recruits human Polycomb 3
García-Cuéllar, M.-P., Zilles, O., Schreiner, S., Birke, M. T., Winkler, T., & Slany, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204108 · Cited by 67
“The INK4A locus that codes for the negative cell cycle regulators p16 and p19ARF is a direct target of Bmi-1 and overexpression of Bmi-1 cooperates with c-Myc by repressing these tumor suppressor proteins (Jacobs et al., 1999a,b).”
BackgroundInduction of senescence by oncogenic ras
Palmero, I., & Serrano, M. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)33060-4 · Cited by 76
Epithelial stem cells and intestinal cancer
Tan, S., & Barker, N. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.005 · Cited by 69
Miyazaki, M., Miyazaki, K., Itoi, M., Katoh, Y., Guo, Y., Kanno, R., Katoh-Fukui, Y., Honda, H., Amagai, T., van Lohuizen, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.12.013 · Cited by 72
Hibino, S., Saito, Y., Muramatsu, T., Otani, A., Kasai, Y., Kimura, M., & Saito, H. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.17 · Cited by 66
van Galen, J. C., Dukers, D. F., Giroth, C., Sewalt, R. G. A. B., Otte, A. P., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200424985 · Cited by 67
Knockdown of RNF2 induces apoptosis by regulating MDM2 and p53 stability
Wen, W., Peng, C., Kim, M., Jeong, C. H., Zhu, F., Yao, K., Zykova, T. A., Ma, W., Carper, A., Langfald, A., et al. (2013) · Oncogene · doi:10.1038/onc.2012.605 · Cited by 66
Kallin, E. M., Cao, R., Jothi, R., Xia, K., Cui, K., Zhao, K., & Zhang, Y. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000506 · Cited by 64
“First, studies on Hox and Ink4a/Arf loci indicate that PRC1 knockdown reduced local uH2A levels which correlate with upregulation of gene expression [7,18,19].”
BackgroundEmerging roles of lnc RNA s in senescence
Montes, M., & Lund, A. H. (2016) · FEBS Journal · doi:10.1111/febs.13679 · Cited by 69
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.
Zindy, F., Nilsson, L. M., Nguyen, L., Meunier, C., Smeyne, R. J., Rehg, J. E., Eberhart, C. G., Sherr, C. J., & Roussel, M. F. (2003) · PubMed · Cited by 78
Modeling Late-Onset Sporadic Alzheimer’s Disease through BMI1 Deficiency
Flamier, A., El Hajjar, J., Adjaye, J., Fernandes, K. J., Abdouh, M., & Bernier, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.097 · Cited by 65
Role of the polycomb group proteins in hematopoietic stem cells
Konuma, T., Oguro, H., & Iwama, A. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01191.x · Cited by 73
“Bmi1 is a potent negative regulator of the Ink4a ⁄ Arf locus (Jacobs et al. 1999).”
BackgroundLiu, Y., Liu, F., Yu, H., Zhao, X., Sashida, G., DeBlasio, A., Harr, M. W., She, Q., Chen, Z., Lin, H., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2003199 · Cited by 73
Takada, Y., Isono, K., Shinga, J., Turner, J. M. A., Kitamura, H., Ohara, O., Watanabe, G., Singh, P. B., Kamijo, T., Jenuwein, T., et al. (2007) · Development · doi:10.1242/dev.02747 · Cited by 65
Yoo, Y. A., Roh, M., Naseem, A. F., Lysy, B., Desouki, M. M., Unno, K., & Abdulkadir, S. A. (2016) · Nature Communications · doi:10.1038/ncomms12943 · Cited by 70
“Bmi1 has a key role in self-renewal and tumorigenesis in various tissues, through mechanisms that are both dependent and independent of repression of the cell cycle regulators p16 Ink4a and p19 ARF (refs 19,20).”
Sánchez‐Beato, M., Sánchez, E., García, J. F., Pérez‐Rosado, A., Montoya, M. C., Fraga, M., Jesús Artiga, M., Navarrete, M., Abraira, V., Morente, M., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1661 · Cited by 64
“Although an inverse relation between BMI1 and p16 expression has been described in experimental studies [28,37], a weak but direct association was found in these HL cases (Phi: 0.”
BackgroundRole of H3K27 Demethylases Jmjd3 and UTX in Transcriptional Regulation
Hübner, M. R., & Spector, D. L. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.020 · Cited by 70
Current Status and Issues in Cancer Stem Cell Study
Yang, Y., & Chang, J. (2008) · Cancer Investigation · doi:10.1080/07357900801901856 · Cited by 69
“Overexpression of Bmi-1 results in downregulation of p16 and p19Arf, which are important antiproliferation protein (54).”
BackgroundRoles of Apoptosis and Cellular Senescence in Cancer and Aging
Cerella, C., Grandjenette, C., Dicato, M. A., & Diederich, M. F. (2016) · Current Drug Targets · doi:10.2174/1389450116666150202155915 · Cited by 71
p16 and ARF: activation of teenage proteins in old age
Satyanarayana, A., & Rudolph, K. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423437 · Cited by 64
Cellular Mechanisms of Somatic Stem Cell Aging
Jung, Y., & Brack, A. S. (2014) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-416022-4.00014-7 · Cited by 61
Zhang, X., Soda, Y., Takahashi, K., Bai, Y., Mitsuru, A., Igura, K., Satoh, H., Yamaguchi, S., Tani, K., Tojo, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.125 · Cited by 66
Hyperoxia‐induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS
Klimova, T. A., Bell, E. L., Shroff, E. H., Weinberg, F. D., Snyder, C. M., Dimri, G. P., Schumacker, P. T., Budinger, G. R. S., & Chandel, N. S. (2009) · The FASEB Journal · doi:10.1096/fj.08-114256 · Cited by 63
“Overexpressing BMI1 can be sufficient to prevent senescence (33, 36).”
BackgroundFisher, M. L., Adhikary, G., Grun, D., Kaetzel, D. M., & Eckert, R. L. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22448 · Cited by 68
Mas-Bargues, C., Viña-Almunia, J., Inglés, M., Sanz-Ros, J., Gambini, J., Ibáñez-Cabellos, J. S., García-Giménez, J. L., Viña, J., & Borrás, C. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.002 · Cited by 62
Telomere‐independent cellular senescence in human fetal cardiomyocytes
Ball, A. J., & Levine, F. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00137.x · Cited by 65
“The INK4A locus is known to be repressed by the Polycomb protein Bmi-1 (Jacobs et al., 1999).”
BackgroundCellular Memory and Hematopoietic Stem Cell Aging
Kamminga, L. M., & de Haan, G. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0345 · Cited by 63
Nguyen, T. H., Mai, G., Villiger, P., Oberholzer, J., Salmon, P., Morel, P., Bühler, L., & Trono, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.036 · Cited by 53
“They were infected with Cre-excisable lentiviral vectors coding for SV40TAg, telomerase (TERT) and Bmi-1, a downregulator of the p16 and p19Arf tumor suppressor genes [18] (ABT cocktail), or for SV40TAg and TERT (AT cocktail).”
MethodHuber, G. F., Albinger‐Hegyi, A., Soltermann, A., Roessle, M., Graf, N., Haerle, S. K., Holzmann, D., Moch, H., & Hegyi, I. (2011) · Cancer · doi:10.1002/cncr.26100 · Cited by 71
“Mean age [range], y 59 [39-81] 57 [37-87] 56 [34-81] .”
Li, Z., Wang, Y., Yuan, C., Zhu, Y., Qiu, J., Zhang, W., Qi, B., Wu, H., Ye, J., Jiang, H., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.123 · Cited by 64
Prostatic preneoplasia and beyond
Joshua, A. M., Evans, A., van der Kwast, T., Zieleńska, M., Meeker, A. K., Chinnaiyan, A. M., & Squire, J. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.12.001 · Cited by 80
Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms
Radulović, V., de Haan, G., & Klauke, K. (2012) · Leukemia · doi:10.1038/leu.2012.368 · Cited by 73
Ohtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2010) · Cell Division · doi:10.1186/1747-1028-5-1 · Cited by 62
“Concluding remarks It is, however, clear that all aspects of p16 regulation cannot be explained by the factors described here, and that the p16 gene is subject to multiple levels of control [15,38,39,64-74].”
Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia
Hansen, G. M., & Justice, M. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203023 · Cited by 62
“Recently it has been shown that the Pc-g repression also controls the expression of critical cell cycle regulators such as p16 and p19Arf (Jacobs et al., 1999).”
BackgroundTokimasa, S., Ohta, H., Sawada, A., Matsuda, Y., Kim, J. Y., Nishiguchi, S., Hara, J., & Takihara, Y. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(00)00620-2 · Cited by 67
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.